CAS Medical Systems (CASM) Tops Q3 EPS by 1006c

CAS Medical Systems (NASDAQ: CASM) reported Q3 EPS of $10.00, $10.06 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $4.5 million versus the consensus estimate of $5.88 million.

For earnings history and earnings-related data on CAS Medical Systems (CASM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c